Tigecycline suppressed mitochondrial functions and metabolism of CML cells and resulted in cell death by via activation of cytochrome-c/ caspase-9/ caspase-3 pathway. This evidence concerns the gene CYCS and chronic myelogenous leukemia, BCR-ABL1 positive.